Express News | China International Capital Corporation: The medical instruments Sector is expected to benefit from product upgrades and overseas exports in 2025.

BreakingsDec 31, 2024 08:08

MicroPort Gets China Registration Nod for Transcatheter Aortic Valve Implantation Device

MT NewswiresDec 18, 2024 15:14

Selected announcements | CHINAHONGQIAO expects annual Net income to nearly double year-on-year; GOLDLION HOLD receives a premium for privatization, resuming trading today.

CHINAHONGQIAO expects that the Net income for the year ending December 31, 2024, may increase by around 95% year-on-year; China Coal Energy's Commodity coal sales for the first 11 months were 0.256 billion tons, showing a decrease of 1.9% year-on-year; November sales were 25.8 million tons, representing a year-on-year increase of 11.4%.

cls.cnDec 18, 2024 08:20

CARDIOFLOW-B (02160.HK): VitaFlow LibertyFlex has been approved for registration by the National Medical Products Administration.

On December 17, Gelonghui announced that CARDIOFLOW-B (02160.HK) has received registration approval from the National Medical Products Administration of China for its independently developed third-generation transcatheter aortic valve implantation (TAVI) product, the VitaFlow LibertyFlex transcatheter aortic valve controllable bend delivery system ("VitaFlow LibertyFlex"). VitaFlow LibertyFlex is an upgraded product of the VitaFlow Liberty delivery system and can be used with the aortic valves that have already been approved by the group.

Gelonghui FinanceDec 17, 2024 22:56

Hong Kong stocks are moving differently | All stocks in the MEDBOT system rose sharply, with MEDBOT-B (02252) at one point gaining over 44%. Shanghai will establish a 10 billion yuan Biomedical industry merger and acquisition Fund.

All MICROPORT stocks are on the rise. As of the time of writing, MEDBOT-B (02252) has surged by 26.05%, trading at 11.66 HKD; MICROPORT (00853) has increased by 11.6%, trading at 6.83 HKD; MICROPORT Neuroscience (02172) is up by 9.14%, trading at 9.79 HKD; and CARDIOFLOW-B (02160) has risen by 2.86%, trading at 0.72 HKD.

Zhitong FinanceDec 11, 2024 15:36

Hong Kong stock concept tracking | Medical devices trade-in program attracts institutional attention, clear trend of market recovery.

"Trade-in" is accelerating in the field of medical devices, and various provinces are intensively issuing "feasibility announcements", "project approval announcements" and "tender procurement notices", injecting a dose of "cardiotonic" into the market.

Zhitong FinanceOct 29, 2024 09:30